End Stage Renal Disease Esrd Drug Market Size And Share

Report Code : TIPRE00016858
Category : Life Sciences

No. of Pages : 150

Buy Now

Marktgröße und Marktanteil von Medikamenten gegen Nierenversagen im Endstadium (ESRD) bis 2025 – 2031

Buy Now

End Stage Renal Disease (ESRD) Drug Market Report Analysis

End Stage Renal Disease (ESRD) Drug Market

CAGR (2023 - 2031)
XX%
Market Size 2023
US$ XX million
Market Size 2031
US$ XX Million

Report Coverage

Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

Key future trends
Detailed PEST/Porter’s Five Forces and SWOT analysis

Industry landscape and competition analysis & recent developments
Detailed company profiles

Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

AbbVie Inc.
Amgen
AstraZeneca
Sanofi
Kyowa Kirin Co., Ltd.
Takeda Pharmaceutical Company Limited
Astellas Pharma Inc.
Bayer AG
Vifor Pharma Management Ltd.

Regional Overview

Nordamerika
Europa
Asien-Pazifik
Süd- und Mittelamerika
Naher Osten und Afrika

Market Segmentation

By Produkttyp

Kalzimimetika
Vitamin D
Sterole
Kaliumbinder
Phosphatbinder auf Kalziumbasis
andere

By Indikation

durch eine Nierenerkrankung im Endstadium

By Vertriebskanal

Krankenhausapotheken
Online-Apotheken
Präsenzapotheken

By Geographie

Nordamerika
Europa
Asien-Pazifik
Süd- und Mittelamerika